Antioxidant Effects of Glutathione and IGF in a Hyperglycaemic Cell Culture Model of Fibroblasts: Some Actions of Advanced Glycaemic end Products (AGE) and Nicotine

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|6|3|279-286

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.6, Iss.3, 2006-01, pp. : 279-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Smooth Muscle Cell Pathophysiology and Advanced Glycation End Products (AGEs)

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 875-881

Bentham Science Publishers

Access to resources Recommend Favorite

Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress

By Xu Huiqin   Shen Jian   Liu Hong   Shi Yan   Li Lihua   Wei Min  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 12, 2006-12 ,pp. : 1267-1273

NRC Research Press

Access to resources Recommend Favorite

Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy - are these Receptors Valid Therapeutic Targets

By  

Current Drug Targets, Vol. 10, Iss. 1, 2009-01 ,pp. : 42-50

Bentham Science Publishers

Access to resources Recommend Favorite

Protective effects of hesperidin derivatives and their stereoisomers against advanced glycation end-products formation

By Li Daxin   Mitsuhashi Shinya   Ubukata Makoto  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 50, Iss. 12, 2012-12 ,pp. : 1531-1535

Informa Healthcare

Access to resources Recommend Favorite

Advanced glycation end products and diabetic complications

By Stitt Alan W   Jenkins Alicia J   Cooper Mark E  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1205-1223

Informa Healthcare

Access to resources Recommend Favorite